H.C. Wainwright Initiates Coverage of Trevi Therapeutics (TRVI) With Buy Rating
On May 28, Oren Livnat, an analyst from H.C. Wainwright initiated coverage of Trevi Therapeutics, Inc. (NASDAQ:TRVI) with a Buy rating and a $21 price target. The update comes after the company released additional analysis from the Phase 2a RIVER trial of Haduvio in patients with Refractory Chronic Cough.
Closeup of a biopharmaceutical worker holding a beaker of white liquid in a laboratory.
The company released additional analysis from phase 2a RIVER trial suggesting a more de-risked path to approval as compared to the current market expectations, said the analyst. He believes that the company can achieve over $1 billion in revenue from the drug's treatment of refractory chronic cough alone. Moreover, the Idiopathic Pulmonary Fibrosis chronic cough could be another significant revenue stream for Trevi Therapeutics, Inc. (NASDAQ:TRVI).
The current market capitalization of the company is around $627 million which is undervalued considering the strong results from the RIVER trial, said the analyst. Livna expects Haduvio to become a best-in-class for both Idiopathic Pulmonary Fibrosis and refractory chronic cough.
Trevi Therapeutics, Inc. (NASDAQ:TRVI) is a clinical-stage biopharmaceutical company focused on developing and commercializing Haduvio, which is an investigational therapy aimed at treating chronic cough in patients with idiopathic pulmonary fibrosis and refractory chronic cough.
While we acknowledge the potential of TRVI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TRVI and that has 100x upside potential, check out our report about the .
READ NEXT: and .
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Everything you need to know about headaches for Headache Awareness Month
NEW HAVEN, Conn. (WTNH) — June is Headache Awareness Month. In today's health headlines, we discuss what to know about the most common headache types, how to tell them apart, and tips for preventing a tension headache. Dr. Vanessa Cooper, Yale Medicine neurologist specializing in headaches and assistant professor at Yale School of Medicine, joined Good Morning Connecticut at 9 a.m. to discuss. Watch the video above to learn more. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
18 minutes ago
- Yahoo
UAE's data center project with U.S. tech firms faces security concerns
-- A massive deal to create one of the world's largest data center hubs in the United Arab Emirates (UAE) with American technology, continues to face persistent security concerns, according to a Friday report by Reuters. The deal, worth billions of dollars, is reportedly far from finalized. The proposed site, spanning 10 square miles, is financed by G42, a tech company linked to the Emirati state. G42 is spearheading the development of the UAE's artificial intelligence (AI) industry. Tech giants Nvidia (NASDAQ:NVDA), OpenAI, Cisco (NASDAQ:CSCO), Oracle (NYSE:ORCL), and Japan's SoftBank (TYO:9984) are collaborating with G42 on the initial phase of the project, dubbed Stargate UAE, which is slated to launch in 2026. However, U.S. officials are yet to establish the security conditions for exporting the advanced chips or how the agreement with the Gulf state will be enforced. This leaves the deal unresolved. During a visit by then-President Trump, Abu Dhabi pledged to align its national security regulations with Washington's, including measures to prevent the misuse of U.S. technology. Concerns remain about the UAE's close ties with China, with the report noting that these issues have been consistent during both Biden and Trump administrations. The primary concern is the reliability of the Gulf state as a strategic partner. The report didn't indicate if new evidence had surfaced, but stated that existing concerns are still not addressed. During Trump's first term, the UAE and other Gulf states proceeded with the deployment of Huawei 5G technology, despite opposition from the U.S. Some U.S. officials also question whether the UAE can effectively prevent American technology from reaching Washington's adversaries, the report added. Related articles UAE's data center project with U.S. tech firms faces security concerns Melius upgrades Deere on long-term tech moat and recurring revenue upside Taseko Mines shares surge on landmark agreement with Tŝilhqot'in Nation
Yahoo
19 minutes ago
- Yahoo
Energy and tech stocks help lift S&P/TSX composite, U.S. stocks also higher
TORONTO — Canada's main stock index was up in late-morning trading, helped by strength in energy and technology sectors, while U.S. stock markets also climbed higher. The S&P/TSX composite index was up 81.84 points at 26,424.13. In New York, the Dow Jones industrial average was up 353.70 points at 42,673.44. The S&P 500 index was up 53.32 points at 5,992.62, while the Nasdaq composite was up 198.88 points at 19,497.33. The Canadian dollar traded for 73.04 cents US compared with 73.21 cents US on Thursday. The July crude oil contract was up US$1.10 at US$64.47 per barrel and the July natural gas contract was up two cents US at US$3.70 per mmBTU. The August gold contract was down US$23.10 at US$3,352.00 an ounce and the July copper contract was down five cents US at US$4.88 a pound. This report by The Canadian Press was first published June 6, 2025. Companies in this story: (TSX:GSPTSE, TSX:CADUSD The Canadian Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
